Jarlego, Cliff S.
HRN: 23 23 12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/08/2023
07/16/2023
IV
4.5gm
QID
Pneumonia High Risk
Checking Final Appropriateness
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes